A date set for the half-year test

Accsys Technologies (LSE:AXS) confirmed on 10 November that it will publish interim results for the six months to 30 September 2026 at 07:00 on 24 November, followed by an analyst and Shareholder webinar at 09:00 that day. A further presentation through Investor Meet Company is scheduled for 2 December.

The notice itself contained no trading figures. Its significance lies in what the interims must clarify: whether the distributor destocking that weighed on the opening months of the financial year has ended, as the company said in September, and whether the second-half recovery management is counting on has begun to appear.

About the company

Accsys Technologies produces Accoya, a modified timber made by treating sustainably sourced softwood through a process called acetylation. The treatment makes wood more durable and dimensionally stable, which suits applications such as windows, doors, decking and cladding where weather exposure is a concern. The company manufactures in Arnhem in the Netherlands and, through its joint venture with Eastman Chemical, at Kingsport, Tennessee.

Because its plants are capital-intensive, profitability depends on running them at high utilisation. A fall in volumes therefore affects Earnings more than Revenue figures alone suggest, which is why the company's Volume reports are followed closely.

What the September update said

In a trading update on 21 September covering the five months to 31 August, Accsys reported group revenue down 6% to €56.9m from €60.4m. Group sales volumes fell 11% to 22,186 cubic metres, while volumes at its US joint venture with Eastman Chemical rose 3% to 6,767 cubic metres.

The company blamed destocking by distributors in all regions, most acutely in North America, alongside cautious purchasing and postponed projects linked to inflation, interest rates and conflict in the Middle East. It said it believed the destocking phase had ended, that customer inventories were stabilising and that September activity was firmer. It expected the first half to improve relative to the five-month figures but still to show revenue and volumes slightly below the prior year.

Why the interims matter

LSE:AXS makes Accoya, a modified timber produced by acetylating sustainably sourced softwood to make it more durable and dimensionally stable. It manufactures at Arnhem in the Netherlands and, through the Accoya USA joint venture in which it holds 60%, at Kingsport, Tennessee. Earnings depend heavily on running these plants at high utilisation, so volume shortfalls feed quickly into profitability.

The September statement guided that underlying EBITDA, excluding the joint venture, would be broadly in line with market expectations despite lower revenue, and that the second half would carry greater weight in both revenue and earnings. That makes the half-year figures an important checkpoint. If the first half lands close to management's description, the full-year outcome rests on a sharper pickup in later months.

Risks to the recovery case

Several dependencies are visible. Management said the US destocking stemmed partly from unusually high inventories built before the Kingsport plant started, and from improved product availability as local output ramped up. That suggests the issue may be structural to the transition, rather than purely cyclical, and could take time to work through. The company also expected only single-digit growth in the United States for the full year.

LSE:AXS itself said it expected challenging macroeconomic conditions to continue. Its outlook relies on new sub-distributor programmes supporting second-half sales and on Phase 1 of its FOCUS strategy, launched in January 2025, which the company said remained on track. Any renewed weakness in construction or renovation spending in Europe or North America would test those assumptions.

Reading the September figures

Revenue fell 6% to €56.9m while group sales volumes dropped 11% to 22,186 cubic metres. The larger fall in volumes than in revenue implies that average selling prices or product mix improved, since a smaller percentage drop in revenue than in volumes would not otherwise occur. The US joint venture moved in the opposite direction, with volumes up 3% to 6,767 cubic metres, showing that the weakness was concentrated outside the joint venture, mainly in the Netherlands-supplied business.

The company's description of destocking is significant. When distributors reduce their inventories, they buy less than their customers consume, so sales to distributors fall even if final Demand is stable. If the destocking has ended, as the company said, sales should recover towards underlying demand without any improvement in the end market.

The Kingsport factor

The US joint venture has a structural effect on the picture. Local production at Kingsport improves product availability in North America, which reduces the need for distributors to hold large stocks or to Import from Europe. That helps explain why destocking was most acute in North America: distributors built inventories ahead of the plant's start and then worked them down as local Supply came on stream. The effect should fade, but the speed at which it does so is hard to forecast.

What second-half weighting implies

Management expects the second half to carry more of the year's revenue and earnings than the first. That expectation relies on sub-distributor programmes, an improvement in September activity and a recovery in customer ordering. For that to hold, the interim results will need to show momentum building after the quarter end. Underlying EBITDA broadly in line with market expectations, despite lower revenue, also suggests that cost control and mix are helping, and that the company believes it can protect profitability while volumes remain subdued.

What to watch on 24 November

The interims should answer three questions: how group volumes in September compared with the weak summer months, whether management still regards its full-year earnings guidance as achievable, and how quickly Kingsport output is translating into sustained sales rather than replacing imported stock.

Private and institutional shareholders can put questions directly at the 2 December presentation, with written questions accepted until 09:00 on 1 December. Commentary on order intake for the remainder of the year to 31 March 2027 is likely to be the clearest indicator of whether the destocking period described in September has passed. The first-half Balance Sheet will also show how the group's cash position has moved since the March year end, which the September update did not quantify.